A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

Clinical trial NCT04975204 · UNKNOWN

Trial details

NCT number: NCT04975204
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Tumor

Start date: 2022-02-18
Primary completion: 2022-12-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.